Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Impact of Interventions to Change CBC and Differential Ordering Patterns in the Emergency Department.

Phelan MP, Nakashima MO, Good DM, Hustey FM, Procop GW.

Am J Clin Pathol. 2019 Jan 7;151(2):194-197. doi: 10.1093/ajcp/aqy128.

PMID:
30247523
2.

A Global Health Research Checklist for clinicians.

Sawaya RD, Breslin KA, Abdulrahman E, Chapman JI, Good DM, Moran L, Mullan PC, Badaki-Makun O.

Int J Emerg Med. 2018 Apr 19;11(1):25. doi: 10.1186/s12245-018-0176-9.

3.

Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression.

Strekalova E, Malin D, Good DM, Cryns VL.

Clin Cancer Res. 2015 Jun 15;21(12):2780-91. doi: 10.1158/1078-0432.CCR-14-2792. Epub 2015 Feb 27.

4.

In silico proteome-wide amino aCid and elemental composition (PACE) analysis of expression proteomics data provides a fingerprint of dominant metabolic processes.

Good DM, Mamdoh A, Budamgunta H, Zubarev RA.

Genomics Proteomics Bioinformatics. 2013 Aug;11(4):219-29. doi: 10.1016/j.gpb.2013.07.002. Epub 2013 Aug 3.

5.

N-terminal peptide sequence repetition influences the kinetics of backbone fragmentation: a manifestation of the Jahn-Teller effect?

Good DM, Yang H, Zubarev RA.

J Am Soc Mass Spectrom. 2013 Nov;24(11):1671-5. doi: 10.1007/s13361-013-0628-7. Epub 2013 Apr 30.

PMID:
23633015
6.

Employment of complementary dissociation techniques for body fluid characterization and biomarker discovery.

Good DM, Rutishauser D.

Methods Mol Biol. 2013;1002:223-32. doi: 10.1007/978-1-62703-360-2_18.

PMID:
23625407
7.

Carbonyl charge solvation patterns may relate to fragmentation classes in collision-activated dissociation.

Yang H, Good DM, van der Spoel D, Zubarev RA.

J Am Soc Mass Spectrom. 2012 Aug;23(8):1319-25. doi: 10.1007/s13361-012-0418-7. Epub 2012 Jun 12.

PMID:
22689324
8.

Radical a-ions in electron capture dissociation: on the origin of species.

Zubarev RA, Good DM, Savitski MM.

J Am Soc Mass Spectrom. 2012 Jun;23(6):1015-8. doi: 10.1007/s13361-012-0374-2. Epub 2012 Apr 17.

PMID:
22528204
9.

Sequence scrambling in shotgun proteomics is negligible.

Goloborodko AA, Gorshkov MV, Good DM, Zubarev RA.

J Am Soc Mass Spectrom. 2011 Jul;22(7):1121-4. doi: 10.1007/s13361-011-0130-z. Epub 2011 Apr 15.

PMID:
21953093
10.

Increased throughput of proteomics analysis by multiplexing high-resolution tandem mass spectra.

Ledvina AR, Savitski MM, Zubarev AR, Good DM, Coon JJ, Zubarev RA.

Anal Chem. 2011 Oct 15;83(20):7651-6. doi: 10.1021/ac201843e. Epub 2011 Sep 28.

11.

Drug target identification from protein dynamics using quantitative pathway analysis.

Good DM, Zubarev RA.

J Proteome Res. 2011 May 6;10(5):2679-83. doi: 10.1021/pr200090m. Epub 2011 Apr 21.

PMID:
21434696
12.

Intellinsity: a tool for visualization and analysis of liquid chromatography/tandem mass spectrometry sampling events.

Xia Q, Good DM, Wenger CD, Coon JJ.

Rapid Commun Mass Spectrom. 2010 Nov 15;24(21):3217-8. doi: 10.1002/rcm.4743. No abstract available.

PMID:
20941771
13.

Are the majority of a(2)-ions cyclic?

Good DM, Marin-Vicente C, Zubarev RA.

Phys Chem Chem Phys. 2010 Nov 7;12(41):13372-4. doi: 10.1039/c0cp00514b. Epub 2010 Sep 20.

PMID:
20856953
14.

Calibration function for the Orbitrap FTMS accounting for the space charge effect.

Gorshkov MV, Good DM, Lyutvinskiy Y, Yang H, Zubarev RA.

J Am Soc Mass Spectrom. 2010 Nov;21(11):1846-51. doi: 10.1016/j.jasms.2010.06.021. Epub 2010 Jul 7.

15.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

16.

Mass spectrometric analysis of body fluids for biomarker discovery.

Good DM, Coon JJ.

Methods Mol Biol. 2009;566:277-91. doi: 10.1007/978-1-59745-562-6_18.

PMID:
20058178
17.

The effect of interfering ions on search algorithm performance for electron-transfer dissociation data.

Good DM, Wenger CD, Coon JJ.

Proteomics. 2010 Jan;10(1):164-7. doi: 10.1002/pmic.200900570.

18.

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon JJ, Mischak H.

Mol Cell Proteomics. 2009 Oct;8(10):2296-307. doi: 10.1074/mcp.M800529-MCP200. Epub 2009 Jun 28.

19.

Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.

Metzger J, Luppa PB, Good DM, Mischak H.

Crit Rev Clin Lab Sci. 2009;46(3):129-52. doi: 10.1080/10408360902805261. Review.

20.

Post-acquisition ETD spectral processing for increased peptide identifications.

Good DM, Wenger CD, McAlister GC, Bai DL, Hunt DF, Coon JJ.

J Am Soc Mass Spectrom. 2009 Aug;20(8):1435-40. doi: 10.1016/j.jasms.2009.03.006. Epub 2009 Mar 14.

21.

A new probabilistic database search algorithm for ETD spectra.

Sadygov RG, Good DM, Swaney DL, Coon JJ.

J Proteome Res. 2009 Jun;8(6):3198-205. doi: 10.1021/pr900153b.

22.

The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.

Zürbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL, Schanstra JP.

Proteomics. 2009 Apr;9(8):2108-17. doi: 10.1002/pmic.200800560.

23.

CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, Novak J, Rossing K, Schanstra JP, Schiffer E, Theodorescu D, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Proteomics Clin Appl. 2008 Jul 10;2(7-8):964.

24.

Urinary proteomics in diabetes and CKD.

Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P; PREDICTIONS Network.

J Am Soc Nephrol. 2008 Jul;19(7):1283-90. doi: 10.1681/ASN.2007091025. Epub 2008 Apr 30.

25.

Discovery and validation of urinary biomarkers for prostate cancer.

Theodorescu D, Schiffer E, Bauer HW, Douwes F, Eichhorn F, Polley R, Schmidt T, Schöfer W, Zürbig P, Good DM, Coon JJ, Mischak H.

Proteomics Clin Appl. 2008 Mar 7;2(4):556-570.

26.

Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.

Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sýkora J, Sládková E, Hes O, Mischak H, McGuire BM.

Electrophoresis. 2007 Dec;28(23):4469-83.

PMID:
18004714
27.

Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.

Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H.

J Proteome Res. 2007 Dec;6(12):4549-55. Epub 2007 Oct 31. Review.

PMID:
17970587
28.

Urinary proteomic biomarkers in coronary artery disease.

Zimmerli LU, Schiffer E, Zürbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter KH, Mischak H, Kolch W, Delles C, Dominiczak AF.

Mol Cell Proteomics. 2008 Feb;7(2):290-8. Epub 2007 Oct 19.

29.

Dual electrospray ion source for electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer.

Williams DK Jr, McAlister GC, Good DM, Coon JJ, Muddiman DC.

Anal Chem. 2007 Oct 15;79(20):7916-9. Epub 2007 Sep 15.

30.

Performance characteristics of electron transfer dissociation mass spectrometry.

Good DM, Wirtala M, McAlister GC, Coon JJ.

Mol Cell Proteomics. 2007 Nov;6(11):1942-51. Epub 2007 Aug 1.

31.

Implementation of electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer.

McAlister GC, Phanstiel D, Good DM, Berggren WT, Coon JJ.

Anal Chem. 2007 May 15;79(10):3525-34. Epub 2007 Apr 19.

32.

Advancing proteomics with ion/ion chemistry.

Good DM, Coon JJ.

Biotechniques. 2006 Jun;40(6):783-9. Review.

33.

Faculty practice: how it enhances teaching.

Good DM, Schubert CR.

J Nurs Educ. 2001 Dec;40(9):389-96.

PMID:
11769949
34.

Social support: gender differences in multiple sclerosis spousal caregivers.

Good DM, Bower DA, Einsporn RL.

J Neurosci Nurs. 1995 Oct;27(5):305-11.

PMID:
8568348
35.

Effects of levcromakalim and RP52891 on NANCe nerve-mediated changes in pulmonary dynamics evoked by vagal stimulation in the guinea-pig.

Clapham JC, Bowring NE, Trail BK, Fuller DA, Good DM.

Pulm Pharmacol. 1993 Sep;6(3):201-8.

PMID:
8219574
36.

Effects of BRL 38227 on neurally-mediated responses in the guinea-pig isolated bronchus.

Good DM, Clapham JC, Hamilton TC.

Br J Pharmacol. 1992 Apr;105(4):933-40.

38.
39.

Spasmogen action in guinea-pig isolated trachealis: involvement of membrane K+-channels and the consequences of K+-channel blockade.

Boyle JP, Davies JM, Foster RW, Good DM, Kennedy I, Small RC.

Br J Pharmacol. 1988 Feb;93(2):319-30.

40.

The spasmogenic action of oxytocin in the rat uterus--comparison with other agonists.

Edwards D, Good DM, Granger SE, Hollingsworth M, Robson A, Small RC, Weston AH.

Br J Pharmacol. 1986 Aug;88(4):899-908.

41.

Training theatre technicians.

Good DM.

Nurs Mirror Midwives J. 1971 Jan 22;132(4):30-1. No abstract available.

PMID:
5205380
42.

Fibrocystic disease of the pancreas after childhood; case report with necropsy at 17 years.

HENDRIX RC, GOOD DM.

Ann Intern Med. 1956 Jan;44(1):166-73. No abstract available.

PMID:
13275859

Supplemental Content

Support Center